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Objectives. The purpose of this study was to compare the
immediate angiographic and long-term results of debulking ver-
sus balloon angioplasty for treatment of true bifurcation lesions.
Background. Previous studies have shown true bifurcation
lesions to be a high risk morphological subset for percutaneous
transluminal coronary angioplasty (PTCA). Although atherec-
tomy devices have been used to treat bifurcation lesions, no
studies have compared the outcomes of these alternative treat-
ment modalities.
Methods. Between January 1992 and May 1997, we treated 70
consecutive patients with true bifurcation lesions (defined as a
greater than 50% stenosis in both the parent vessel and contigu-
ous side branch) with conventional PTCA (n 5 30) or debulking
(with rotational or directional atherectomy) plus adjunctive
PTCA (n 5 40). Paired angiograms were analyzed by quantitative
angiography, and clinical follow-up was obtained in all patients.
Results. Acute procedural success was 73% in the PTCA group
and 97% in the debulking group (p 5 0.01). Major in-hospital
complications occurred in two patients in the PTCA group and
one in the debulking group. Treatment with atherectomy plus
PTCA resulted in lower postprocedure residual stenoses than
PTCA alone (16 6 15% vs. 33 6 17% in the parent vessel, and 6 6
15% vs. 39 6 22% in the side branch; p < 0.001 for both
comparisons). At 1 year follow-up, the incidence of target vessel
revascularization (TVR) was 53% in the PTCA group as compared
with 28% in the debulking group (p 5 0.05). Independent predic-
tors of the need for repeat TVR were side branch diameter
>2.3 mm, longer lesion lengths, and treatment with PTCA alone.
Conclusions. For the treatment of true bifurcation lesions,
atherectomy with adjunctive PTCA is safe, improves acute angio-
graphic results, and decreases target vessel revascularization
compared to PTCA alone. The benefits of debulking for bifurca-
tion lesions were especially seen in lesions involving large side
branches.
(J Am Coll Cardiol 1998;32:1845–52)
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True bifurcation lesions occur in 2% to 16% of stenoses being
considered for percutaneous coronary intervention (1–3). Such
bifurcation morphology has been shown consistently to be
associated with reduced acute success and higher complication
rates after treatment by conventional balloon angioplasty
(2,4,5). The higher rate of complications may relate to plaque
shifting, ostial recoil and propagation of dissection (1,5) as well
as endothelial dysfunction occurring specifically at coronary
bifurcations (6). For this reason, multiple approaches have
been used to treat such lesions including double wire and
kissing balloon angioplasty (3,7–9), directional atherectomy
(1,10–13), rotational atherectomy (14), and most recently
complex applications of coronary stents (15–19). To date,
however, there have been no direct comparisons of balloon
angioplasty and other treatment modalities for patients with
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such lesions in order to establish the relative merits of newer
devices compared to balloon angioplasty alone. For this rea-
son, we analyzed in-hospital results and long-term outcomes
for 70 consecutive patients with true bifurcation lesions treated
with either conventional PTCA (percutaneous transluminal
coronary angioplasty) or debulking (with rotational or direc-
tional atherectomy) plus adjunctive PTCA.
Methods
Study population. Between January 1, 1992, and May 31,
1997, a total of 70 patients underwent percutaneous coronary
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revascularization at Beth Israel–Deaconess Medical Center for
management of symptomatic true bifurcation lesions. This
represented 1.2% of all coronary interventions during that
time period. Only lesions in which there was a .50% diameter
stenosis in both the parent vessel and the ostium of the
contiguous side branch with reference diameter .2.0 mm were
considered. Of these 70 patients, 30 were treated with balloon
angioplasty alone (PTCA group), and 40 were treated with a
combination of either rotational atherectomy or directional
atherectomy (DCA) and adjunctive PTCA (debulking group).
In general, PTCA was performed in the earlier portion of the
study period (1992 to 1994) and debulking was performed
during the later years (1995 to 1997).
Interventional procedures. As previously described, PTCA
for true bifurcation lesions was performed using a double-wire
technique in which simultaneous (“kissing”) or sequential
balloon inflations were performed in both vessels (7–9,20).
Directional atherectomy was our treatment of choice in larger
noncalcified vessels and was performed according to standard
techniques without the use of a nitinol wire for side branch
protection (10–12,21). A series of four to eight circumferential
cuts were performed at an inflation pressure of 10 to 40 psi, first
in the parent and then in the side branch. If the vessel was greater
than 3.2 mm in diameter, we generally used a 7F atherectomy
catheter. If the vessel was 2.5 to 3.2 mm in diameter, a 6F
atherectomy catheter was used. Rotational atherectomy was
performed sequentially in the parent and side branch using an
alternating “stepped burr” approach, with placement of the wire
sequentially in both branches for each sized burr (14,22). We
generally began with a 1.5- to 1.75-mm burr and increased in
0.25-mm to 0.5-mm increments to a final burr size corresponding
to 60% to 80% of each reference vessel diameter.
Following completion of either rotational or DCA, adjunc-
tive kissing balloon angioplasty was performed in all cases,
generally at low inflation pressures (2 to 8 atm). Vascular
access sheaths were removed once the activated clotting time
was #180 s. Intravenous heparin was then restarted and
administered overnight. Myocardial infarction was diagnosed
if any postprocedure creatine kinase measurement was $2
times the upper limit of normal (200 IU/ml) with a positive MB
fraction or if new Q waves appeared on the 12-lead electro-
cardiogram.
Angiographic analysis and clinical follow-up. Quantitative
analysis of the coronary segments was performed using a
validated, automated edge-detection algorithm (23), with the
dye-filled catheter as a reference. The diameter of the normal
segment proximal to the traced area in the parent vessel was
used to determine the parent reference diameter, and the side
branch reference diameter was determined from the diameter
of the traced area in the normal segment distal to the lesion in
the branch. The minimal luminal diameter, reference diameter
and percent stenosis were calculated as the mean values from
multiple projections. Lesion length was defined as the distance
from the proximal to the distal shoulder of the lesion. Throm-
bolysis in Myocardial Infarction trial (TIMI) grade flow was
assessed by frame counts using a digital frame counter, as
previously described (24).
Bifurcation lesion type was classified according to the Duke
system (25). Class D bifurcations were defined as .50%
diameter stenosis in the proximal and distal parent vessel and
a .50% stenosis in the ostium of the contiguous side branch
(Fig. 1A). Class F bifurcations were defined as .50% diameter
stenosis in the proximal parent vessel, and .50% diameter
stenosis in the contiguous side branch ostium but no significant
stenosis of the parent vessel beyond the bifurcation (Fig. 1B).
Side branch compromise was defined as abrupt closure or
decrease in TIMI grade flow in the side branch at any time
during the procedure. Procedural success was defined as
achievement of a residual stenosis ,50% in both the parent
vessel and side branch in the absence of any major complica-
tions (death, Q wave myocardial infarction [MI] or repeat
revascularization) prior to hospital discharge.
Clinical follow-up was obtained at 1 month, 6 months, and
1 year after treatment and annually thereafter to determine
Abbreviations and Acronyms
CABG 5 coronary artery bypass grafting
DCA 5 directional atherectomy
MI 5 myocardial infarction
MLD 5 minimum lumen diameter
PTCA 5 percutaneous transluminal coronary angioplasty
TVR 5 target vessel revascularization
Figure 1. Coronary angiograms
demonstrating true bifurcation le-
sions. Duke class D lesion (A) with
an 85% stenosis in the proximal
LAD and an 89% stenosis in the
distal LAD and with a 77% stenosis
in the ostium of the contiguous diag-
onal branch. Duke class F lesion (B)
with an 84% stenosis in the proximal
LAD and a diffuse 65% stenosis in
the ostium and proximal portion of
the diagonal branch.
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each patient’s vital status and need for subsequent revascular-
ization. Target vessel revascularization (TVR) was defined as
any repeat percutaneous intervention to the target vessel
(parent or side branch) or any coronary bypass graft to the
treated vessel during follow-up.
Statistical analysis. Discrete data are presented as fre-
quencies, and continuous data as mean 6 SD. Continuous data
were compared using Student’s t test, and frequencies were
compared using the Fisher exact test. Estimates of event-free
survival and freedom from TVR were determined using the
Kaplan-Meier method (26) and are displayed as standard
survival curves. The univariate relationship between individual
covariates and the need for subsequent target vessel revascu-
larization was assessed using the log-rank statistic. A p value
#0.05 was considered statistically significant. A multivariable
proportional hazards model (27) was used to identify the
independent effect of treatment strategy on TVR while adjust-
ing for baseline differences in vessel size, lesion length, diabe-
tes and additional preprocedure variables identified as predic-
tors of TVR in the univariate analysis. Finally, stepwise
regression analysis was performed to identify those variables
associated with repeat TVR. Factors considered for the step-
wise regression model included patient age, gender, hypercho-
lesterolemia, diabetes mellitus, smoking status, vessel treated,
reference vessel diameter (parent and branch), lesion length
(parent and branch), minimum lumen diameter (MLD) (par-
ent and branch), bifurcation type, calcification, use of adjunc-
tive abciximab and treatment strategy. All analyses were
performed using the STATA 3.0 statistical package (Comput-
ing Resource Center, Santa Monica, California).
Results
Patient characteristics. The treatment groups were gener-
ally well matched with respect to age, gender, risk factors and
lesion location (Table 1). Preprocedure angiographic charac-
teristics were also well matched between the two treatment
groups (Table 2). Approximately 70% of the patients had class
D bifurcation lesions (“Mercedes-Benz” configuration) and
30% had class F lesions according to the Duke classification
scheme (Fig. 1) (25). There were no differences in the baseline
lesion severity or flow velocity as assessed by the TIMI frame
count. There were no differences in operator experience in the
debulking (7.4 6 5.3 years) versus PTCA (7.6 6 3.9 years)
groups (p 5 0.86).
In the debulking group, 34 (85%) patients underwent DCA
and 6 patients received rotational atherectomy (15%). Rota-
tional atherectomy was performed with 1 to 2 burrs with a size
range of 1.5 to 2.15 mm in the parent branch, and 1.25 to
1.75 mm in the side branch. Directional coronary atherectomy
was performed with a 7F device in 27 parent vessels (79%) and
in 23 side branches (68%); the remainder of the lesions were
treated with a 6F device. Two patients in the debulking group
received stents in the parent vessel, one owing to inadequate
lesion expansion, and the other to a moderate parent vessel
dissection. The final balloon size was similar in the debulking
and PTCA groups in both the parent vessel (3.2 6 0.7 mm vs.
3.0 6 0.4 mm, p 5 0.10) and side branch (2.8 6 0.9 vs. 2.5 6
0.4, p 5 0.10). The maximum inflation pressures were signifi-
cantly lower in the debulking group for both the parent vessel
(5.1 6 3.3 vs. 7.0 6 1.8 atm, p 5 0.007) and side branch (4.0 6
2.4 vs. 7.0 6 2.3 atm, p 5 0.001). Abciximab was administered
to seven patients in the debulking group compared to none in
the PTCA group (p 5 0.04).
In-hospital results and complications. Procedural success
was 73% in the PTCA group and 97% in the debulking group
(p 5 0.01). This difference was mainly due to failure to achieve
a ,50% residual stenosis in the side branch of seven (23%)
patients in the PTCA group. There were no deaths in either
Table 1. Baseline Clinical Characteristics
PTCA Group
(n 5 30)
Debulking Group
(n 5 40)
Age (yr) 61 6 12 57 6 10
Male (%) 22 (73) 28 (70)
Hypertension (%) 17 (57) 26 (65)
Hypercholesterolemia (%) 18 (60) 30 (75)
Diabetes mellitus (%) 5 (17) 13 (33)
Current smoker (%) 13 (43) 15 (38)
Previous bypass surgery (%) 0 (0) 3 (7.5)
Extent of coronary artery disease
One vessel (%) 16 (53) 26 (65)
Two vessel (%) 11 (37) 10 (25)
Three vessel (%) 3 (10) 4 (10)
Bifurcation lesion location
LAD/Diagonal (%) 18 (60) 31 (78)
Circumflex/Obtuse marginal (%) 9 (30) 9 (23)
Right coronary artery/PDA (%) 3 (10) 0 (0)
LAD 5 left anterior descending artery; PDA 5 posterior descending artery.
For all comparisons between the debulking and PTCA groups, p . 0.05.
Table 2. Baseline Angiographic Characteristics
PTCA
(n 5 30)
Debulking
(n 5 35)
Bifurcation Classification
Class D (%) 21 (70) 25 (71)
Class F (%) 9 (30) 10 (29)
Preprocedure measurements
Parent
Reference diameter (mm) 2.94 6 0.79 2.98 6 0.66
MLD (mm) 0.60 6 0.18 0.61 6 0.30
% Stenosis 80 6 8 79 6 10
Length (mm) 9.0 6 6.7 9.0 6 4.6
Side Branch
Reference diameter (mm) 2.32 6 0.50 2.31 6 0.50
Diameter .2.3 mm (%) 14 (47) 19 (54)
MLD (mm) 0.72 6 0.23 0.77 6 0.28
% Stenosis 69 6 9 67 6 10
Length (mm) 3.3 6 2.6 3.6 6 3.8
Quantitative angiography could not be performed for five patients in the
debulking group because of incomplete angiographic views or missing cinean-
giograms. For all comparisons between the debulking and PTCA groups, p .
0.10.
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group. In the debulking group, one patient had a coronary
dissection that led to abrupt closure, MI and emergent coro-
nary artery bypass grafting (CABG). In the PTCA group, one
patient had a Q wave MI on the day following the procedure,
and another patient had abrupt closure 2 days after the
procedure leading to emergent CABG.
In the debulking group, transient side branch compromise
occurred in eight patients (22%) as compared with only one
patient (3%) in the PTCA group (p 5 0.06). Each episode of
side branch compromise in the debulking group was transient,
as the snow-plowed branches could invariably be rescued
(despite the absence of a protecting guide wire). In fact, all
patients in the debulking group had TIMI-III flow at the
completion of the procedure. Moreover, despite more fre-
quent transient side branch loss in the debulking group, there
was no difference in periprocedural MI between the two
groups (5% vs. 3%, p 5 NS).
Acute angiographic results (Table 3). The MLD of the
parent vessel increased from 0.61 6 0.30 mm to 2.09 6
0.65 mm after initial debulking alone, and further increased to
2.48 6 0.57 mm after adjunctive PTCA (Fig. 2, p , 0.001 for
both comparisons). Similar benefits were seen for the branch
vessel as well. The final MLDs in the parent vessel (2.48 6 0.57
vs. 1.97 6 0.65 mm) and the branch vessel (2.22 6 0.53 vs.
1.39 6 0.55 mm) were substantially larger in the group treated
with initial debulking as compared with PTCA alone (p ,
0.001 for both comparisons). Patients treated with initial
debulking also had less frequent persistent dissections in the
parent vessel or side branch (9% vs. 33%, p 5 0.03) and
improved coronary flow velocities in the side branches as
judged by the TIMI frame counts (19 6 5 vs. 24 6 12, p 5
0.03).
Late clinical results. Clinical follow-up was available for all
patients with a median duration of 2.0 years in the debulking
group and 3.8 years in the PTCA group with 6-month
follow-up available for 68 of 70 (97%) of patients. According
to Kaplan-Meier analysis, there was no significant difference in
mortality or the occurrence of MI between the PTCA and
debulking groups, respectively (Table 4). In contrast, the need
for subsequent TVR was significantly reduced in patients
treated with debulking plus adjunctive PTCA as compared
with balloon angioplasty alone (Fig. 3). At 1-year follow-up,
the incidence of repeat TVR was 28% in the debulking group
as compared with 53% for the PTCA group (p 5 0.05). The
extent of TVR differed between the two treatment groups as
Figure 2. Cumulative frequency distribution of minimum lumen di-
ameter at baseline, after PTCA alone or after combined debulking and
adjunctive PTCA as shown for the parent vessel (A) and the side
branch (B). The final minimum lumen diameter after debulking plus
postdilation was significantly larger than after balloon dilation alone in
both the parent vessel (2.48 6 0.57 vs. 1.97 6 0.65 mm, p 5 0.001) and
the side branch (2.22 6 0.53 vs. 1.39 6 0.55 mm, p , 0.001). (A) Open
triangles 5 PTCA baseline; open circles 5 debulking baseline; solid
squares 5 PTCA final; solid triangles 5 debulking final. (B) Open
triangles 5 debulking baseline; solid triangles 5 debulking final; open
squares 5 PTCA baseline; solid squares 5 PTCA final.
Table 3. Final Angiographic Results After PTCA Alone or
Debulking Plus Adjunctive PTCA
PTCA
(n 5 30)
Debulking/
PTCA
(n 5 35) p Value
Parent vessel
Reference diameter (mm) 2.95 6 0.68 2.98 6 0.64 0.86
MLD (mm) 1.97 6 0.65 2.48 6 0.57 0.001
Acute gain (mm) 1.39 6 0.68 1.86 6 0.62 0.006
% Stenosis 33 6 17 16 6 15 , 0.001
Minor dissection (%) 7 (23) 1 (3) 0.03
Side branch
Reference diameter (mm) 2.31 6 0.46 2.37 6 0.45 0.60
MLD (mm) 1.39 6 0.55 2.22 6 0.53 , 0.001
Acute gain (mm) 0.69 6 0.35 1.44 6 0.53 , 0.001
% Stenosis 39 6 22 6 6 15 , 0.001
Minor dissection (%) 3 (10) 2 (6) 0.86
Transient side branch
compromise (%)
1 (3) 8 (22) 0.06
Abbreviations as in Table 2. Minor dissection 5 ACC/AHA Type A or B
dissection.
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well. While most patients in our series who underwent TVR
required treatment of at least the parent vessel, patients in the
PTCA-only group were much more likely to require retreat-
ment of the sidebranch as well (100% vs. 54%, p 5 0.02).
Stepwise multivariable regression analysis identified greater
lesion length and sidebranch diameter .2.3 mm as preproce-
dure characteristics associated with late TVR (Table 5). After
adjusting for baseline differences in these characteristics, treat-
ment with debulking remained an independent predictor of
late TVR with a relative risk of 0.4 (95% CI, 0.2 to 1.0).
Neither the use of adjunctive abciximab nor the type of
debulking procedure (DCA vs. rotational atherectomy) had an
influence on late TVR. The benefits of debulking were most
pronounced for patients with large side branches (Fig. 4). For
those patients with side branch diameters .2.3 mm, the
6-month incidence of TVR was 29% with debulking and 64%
with simple PTCA (p 5 0.03).
Discussion
Significant improvements in device technology over the past
decade have allowed the expanded use of percutaneous coro-
nary interventions in higher risk clinical scenarios and specific
morphological subsets that previously were associated with
poor outcomes with balloon angioplasty alone (28). One such
subset is bifurcation coronary lesions, which have been shown
consistently to be associated with higher rates of acute com-
plications and clinical restenosis when treated with PTCA
(2,4,5). Consequently, a variety of new devices including DCA,
rotational atherectomy, and various coronary stent configura-
tions have been used in an attempt to treat these challenging
lesions (10–19). To date, however, there have been no studies
comparing the acute or long-term results of these techniques.
In this study, we compared the in-hospital and long-term
outcome of treatment of true bifurcation lesions with PTCA or
a debulking strategy using atherectomy followed by adjunctive
PTCA. We found that treatment of true bifurcation lesions
with mechanical debulking techniques was safe compared with
conventional balloon dilation. Moreover, debulking followed
by adjunctive postdilation was associated with a significant
improvement in procedural success (97% vs. 73%, p 5 0.01)
and the attainment of larger postprocedure lumen diameters in
both the parent and branch vessel. Most importantly, we found
that the debulking strategies resulted in improved late clinical
outcomes, with a reduction in the need for repeat TVR at
1-year follow-up from 53% to 28% (p 5 0.05).
Comparison with previous studies. Our results are gener-
ally comparable to the results of previous small series of the
broader population of bifurcation lesions. Studies of PTCA for
bifurcation lesions have reported acute procedural success
rates of 74% to 94% (2,5,9) with residual stenoses of 30% to
40% in both the parent vessel and side branch (5,20,29)—
similar to the results we observed. Several previous studies
have reported clinical restenosis rates of 37% to 42% after
PTCA for bifurcation lesions (3,9). The fact that our PTCA
results are somewhat inferior to these historical results may
relate to the inclusion of only the highest risk subset of
bifurcation lesions in our series. Most prior studies of “bifur-
cation” lesions have included many patients without a signifi-
cant stenosis in a major contiguous side branch (3,4,20,29–
33)—lesions with a lower risk of acute and long-term
complications than true bifurcations (30,31,33).
Previous studies of DCA or rotational atherectomy have
demonstrated that these techniques can be accomplished
safely in selected bifurcation lesions (11–14). In the largest
series reported to date, Lewis and colleagues used DCA with a
double-wire technique to achieve procedural success in 97% of
patients, with a residual stenosis of 12% in the parent vessel
and 17% in the side branch (11)—similar to the results we
obtained. In the original multicenter Rotablator experience,
bifurcation lesions comprised 27% of the registry, and proce-
dural success rate for these lesions was 95%; how many of
these were true bifurcation lesions treated with ablation in
both the parent vessel and side branch is unclear (14,22).
Our study serves to expand our understanding of the
percutaneous treatment of bifurcation coronary lesions in
several ways. First, this is the largest series to date of
patients treated with atherectomy techniques for true bifur-
cation lesions. Moreover, this is the first study to directly
Figure 3. Kaplan-Meier estimates of the need for repeat target vessel
revascularization after treatment of true bifurcation lesions by either
PTCA alone or debulking plus adjunctive PTCA.
Table 4. One-Year Event Rates According to
Kaplan-Meier Analysis
Balloon Alone
(n 5 30)
Debulking/PTCA
(n 5 40) p-Value*
Death 7% 0% 0.10
MI 14% 2% 0.09
Coronary bypass surgery 21% 2% 0.05
TVR 53% 28% 0.05
Death, MI or TVR 56% 30% 0.05
TVR 5 target vessel revascularization. MI 5 Q-wave myocardial infarction.
*p Values are based on the log-rank statistic.
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compare the acute results of treatment for bifurcation
lesions with both conventional PTCA and atherectomy
techniques. Finally, by examining long-term outcomes, ours
is the first study to clearly demonstrate the clinical benefits
of debulking techniques over conventional PTCA for such
patients.
Safety of atherectomy without side branch protection.
Previous studies have suggested that debulking—primarily
with DCA—is associated with a higher incidence of side
branch loss and associated periprocedural infarction than
PTCA (29). These observations have led to the development
of bifurcation atherectomy techniques using a second nitinol
guide wire to protect the adjacent side branch (11,13). Our
experience with true bifurcation lesions suggests that, with
careful attention to technique, treatment with debulking
techniques can be performed safely without the need to
protect the side branch. Consistent with previous studies, we
observed a higher incidence of transient side branch com-
promise with debulking than with conventional PTCA (22%
vs. 3%). Nonetheless, in all cases the side branch was
successfully rescued, and in no case did transient side
branch loss lead to periprocedural infarction. These findings
are in contrast to the experience in the CAVEAT trial, in
which side branch compromise occurred in 15% of atherec-
tomy patients and was associated with a 9% incidence of
periprocedural infarction (29). It is likely that many of the
side branches occluded in CAVEAT were relatively small
and not aggressively rescued, however, thus contributing to
the relatively high incidence of periprocedural infarction.
Benefits of debulking. It should not be surprising that
debulking resulted in substantially better acute angiographic
results than conventional PTCA in true bifurcation lesions.
In the BOAT trial, DCA resulted in a mean residual stenosis
of 15% as compared with 28% for PTCA (34). These results
are virtually identical to those we observed in the parent
vessel in this study. The benefits of debulking were even
more striking for the side branches, where the average acute
gain was more than twice that achieved with PTCA alone
(1.44 vs. 0.69 mm, p , 0.001). These benefits likely reflect
the ability of atherectomy techniques to limit both elastic
recoil and “plaque shifting,” both of which frequently
compromise the results of simple balloon dilation for ostial
disease. Given the significant differences in acute angio-
graphic results between the two treatment groups, the
improved clinical outcome seen with debulking in this study
should not be surprising. Previous studies have identified
postprocedure MLD as the principal determinant of resten-
osis after PTCA (35), DCA (34 –36), excimer laser angio-
plasty (37), and coronary stenting (38). In the case of
bifurcation lesions, the ability of two separate lesions to
contribute independently to the process of clinical resteno-
sis would be expected to magnify this relationship.
In addition to reducing the need for repeat TVR in patients
with bifurcation lesions, the use of debulking techniques
appears to reduce the complexity of subsequent interventions
as well. Among patients who developed clinical restenosis in
our study, patients in the debulking group were less likely to
require treatment of both the parent and side branch at
follow-up as compared with those patients in the PTCA group
(54% vs. 100%, p 5 0.02). This led to simple percutaneous
management of restenosis (frequently with stenting of the
parent vessel only) in 10 of 13 patients in the debulking group
who required repeat TVR. In contrast, those patients treated
with initial PTCA who returned with clinical restenosis invari-
ably required treatment of both the parent vessel and side
branch, leading to more complex second interventions with
Figure 4. Six-month target vessel revascularization (TVR) rates ana-
lyzed according to the dichotomous variable of side branch diameter
(.2.3 mm). In patients with large side branches, there was a significant
reduction in the incidence of target vessel revascularization (29% vs.
64%, p 5 0.03), but the TVR rates were not significantly different for
patients with smaller side branches (19% vs. 29%, p 5 NS).
Table 5. Univariate and Multivariate Predictors of Target Vessel Revascularization
Variable
Relative Hazard Ratio
Univariate
(95% CI) p Value
Multivariate
(95% CI) p Value
Side branch diameter .2.3 mm 3.1 (1.3–7.4) 0.02 2.8 (1.2–6.4) 0.01
Debulking group 0.5 (0.2–1.0) 0.05 0.4 (0.2–1.0) 0.04
Lesion length of parent vessel
(per 10 mm)
1.7 (1.0–2.9) 0.07 1.8 (1.0–3.3) 0.04
LAD location 0.5 (0.2–1.0) 0.05
CI 5 confidence interval; LAD 5 left anterior descending artery.
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higher rates of recurrent restenosis and subsequent bypass
surgery. As a result, the 1-year incidence of CABG was
significantly lower for patients treated with initial debulking as
opposed to PTCA (2% vs. 21%, p 5 0.05).
Study limitations. The major limitation of our study is its
retrospective, observational design with possible confounding
by baseline differences in patient characteristics. The fact that
debulking was retained in our multivariable analysis as an
independent predictor of freedom from TVR, however, lends
considerable support to the validity of this finding. Our study is
further limited by the lack of routine angiographic follow-up.
Nonetheless, the ultimate goal of percutaneous coronary re-
vascularization is relief of angina and avoidance of additional
procedures, both of which were accomplished more frequently
with the debulking strategy. Finally, our study is unable to
address questions as to the potential benefits of coronary
stenting for bifurcation stenoses (15–19). However, the appli-
cation of current stent designs to bifurcation lesions poses a
number of technical challenges that frequently lead to un-
stented gaps, difficulties with simultaneous stent delivery, and
possibly increased risks inherent in the use of multiple stents
(6,39). Given the results of atherectomy for such patients,
future studies of the outcomes of stenting for bifurcation
lesions should be compared with the excellent results achieved
using debulking techniques.
Clinical implications. In this observational study, we found
that for treatment of true bifurcation lesions, a strategy of
initial debulking with either DCA or rotational atherectomy
followed by adjunctive PTCA resulted in improved procedural
success and a lower need for repeat TVR during follow-up,
especially in patients with larger side branches. These findings
suggest that optimal treatment for bifurcation lesions should
be defined based on the size of the involved sidebranch. For
patients with a side branch .2.3 mm in diameter, initial
debulking with directional or rotational atherectomy followed
by adjunctive balloon dilation appears to produce the best
long-term outcome. If the side branch is smaller, however, the
benefits of debulking on late outcome appear minimal. In this
case, primary definitive treatment of the parent vessel with
PTCA or stenting would appear reasonable, with subsequent
rescue of the side branch if necessary.
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